Journal Guide

Lipids in Health and Disease is ready to receive manuscripts on all aspects of lipids in health and disease.

Liver cancer has a very high prevalence among cancers in general and is one of the most common causes of death worldwide. Based on these facts, the journal Liver Cancer serves the growing need to better understand the causes, mechanisms, and therapy of the malignancy. It provides the international community of researchers and clinicians with a platform for their research results, focusing on molecular carcinogenesis, prevention, surveillance, diagnosis, and treatment, including molecular targeted therapy, of the disease. Liver Cancer publishes clinical and translational research related to the field of liver cancer in both humans and experimental models in the form of original and review articles.

Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies.

Since the first application of liver transplantation in a clinical situation was reported more than twenty years ago, there has been a great deal of growth in this field and more is anticipated. As an official publication of the AASLD and the ILTS , Liver Transplantation delivers current, peer-reviewed articles on surgical techniques, clinical investigations and drug research - the information necessary to keep abreast of this evolving specialty.

Logopedics Phoniatrics Vocology is the official journal of the British Voice Association. The Journal is an amalgamation of the former journals Scandinavian Journal of Logopedics & Phoniatrics and VOICE. The intention is to cover topics related to speech, language and voice pathology as well as normal voice function in its different aspects. The Journal covers a wide range of topics, including: Read More: http://informahealthcare.com/page/log/Description.

Lung publishes original articles, reviews and editorials on all aspects of the healthy and diseased lungs, of the airways, and of breathing. Epidemiological, clinical, pathophysiological, biochemical, and pharmacological studies fall within the scope of the journal. Case reports, short communications and technical notes can be accepted if they are of particular interest.

Original research articles, early reports, review articles, commentaries and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.

Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.

Manuscripts should be submitted online at http://ees.elsevier.com/lungcancer and the instructions on this site should be closely followed.

If you wish your article to be freely available online immediately upon publication (as some funding bodies now require), you can opt for it to be included in SAGE Choice upon payment of a publication fee. Manuscript submission and refereeing procedure is unchanged, but on acceptance of your article you will be asked to let SAGE know directly if you are choosing SAGE Choice.If funding has been provided for your research, convention dictates that you acknowledge the source and grant information in the Acknowledgements section of your article. Please note that in some cases, grant funders require authors to attribute the funding source, describe the role of the study funding body and include the relevant grant reference numbers.

lupus, systemic lupus nephritis, rheumatology

Lymphatic Research and Biology, a quarterly peer-reviewed journal, provides an interdisciplinary forum for the world's leading biomedical investigators to discuss current and anticipated developments in lymphatic biology and pathology.The Journal features fundamental scientific research of relevance to the lymphatic system. Original work emanates from a variety of investigative disciplines, including genetics, biochemistry and biophysics, cellular and molecular biology, physiology and pharmacology, anatomy, developmental biology, and pathology. The Journal also encourages the submission of state-of-the art reviews in focus areas such as vasculogenesis and angiogenesis, the genetics of lymphatic disorders, muscle cell biology, interstitial signaling mechanisms, and others.